/IDYA

IDEAYA Biosciences Inc

IDYA

$37.59USD↑+0.37%+0.14 today

MARKET CAP

3.6B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$37 – $38

52W RANGE

$24

$43

AI Summary

Stalk

StalkMedium

IDYA has printed a Bullish Exhaustion candle at recent highs amid extreme overbought conditions, signaling waning upside momentum. Despite a Stage 2 advancing structure with price above rising EMAs and an uptrend, short-term weakness into the 9/21 EMA zone deters immediate entry. Medium-term bias remains bullish, but deferred pullbacks into the rising EMA support zone should be monitored for acceptance before engaging.

↑Phase 2/3 darovasertib + crizotinib trial achieved 6.9-month median PFS
↑Generated $8.9M in Q2 collaboration revenue
↓Reported Q2 net loss of $112.5M, wider than Q1

Full analysis →

Buying

6

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
JH Janus Henderson Group Plc Q1 2026	BUY	14.53 M	484.05 M	+7.34 M	+94.9%	0.12%
BI Blackrock, Inc. Q2 2026	BUY	8.89 M	331.45 M	+451.13 K	+17.8%	0.00%
FA Fisher Asset Management, LLC Q2 2026	SELL	851.31 K	31.73 M	+-31.39 K	+7.9%	0.01%
RI Rtw Investments, LP Q2 2026	BUYNEW	370.37 K	13.80 M	+370.37 K	+0.0%	0.12%
CA Citadel Advisors LLC Q2 2026	SELL	366.74 K	13.67 M	+-406.36 K	-46.9%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	BUY	297.56 K	11.09 M	+89.22 K	+59.8%	0.01%
JC Jpmorgan Chase & Co Q2 2026	SELL	267.49 K	9.93 M	+-24.61 K	+8.1%	0.00%
MG Man Group Plc Q2 2026	BUY	245.49 K	9.15 M	+73.65 K	+59.8%	0.01%
WP Woodline Partners LP Q2 2026	SELL	201.67 K	7.52 M	+-201.67 K	-44.1%	0.02%
AC Aqr Capital Management LLC Q2 2026	BUY	67.98 K	2.53 M	+25.81 K	+80.3%	0.00%
MM Millennium Management LLC Q2 2026	SELL	10.50 K	391.33 K	+-345.28 K	-96.7%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	431.00	16.06 K	+-101.00	-9.4%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-327.90 K	-100.0%	0.00%